
Jon E. Angell
Examiner (ID: 3741, Phone: (571)272-0756 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1637, 1674 |
| Total Applications | 1431 |
| Issued Applications | 721 |
| Pending Applications | 199 |
| Abandoned Applications | 530 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4946549
[patent_doc_number] => 20080302675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'POLYMER-BASED CARDIOVASCULAR BIOSENSORS, MANUFACTURE, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/134938
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4038
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0302/20080302675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12134938
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/134938 | POLYMER-BASED CARDIOVASCULAR BIOSENSORS, MANUFACTURE, AND USES THEREOF | Jun 5, 2008 | Abandoned |
Array
(
[id] => 5304546
[patent_doc_number] => 20090299198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'ESTIMATING PULMONARY ARTERY DIASTOLIC PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 12/129955
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5105
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20090299198.pdf
[firstpage_image] =>[orig_patent_app_number] => 12129955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/129955 | ESTIMATING PULMONARY ARTERY DIASTOLIC PRESSURE | May 29, 2008 | Abandoned |
Array
(
[id] => 5491142
[patent_doc_number] => 20090292213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'Circulatory monitoring systems and methods'
[patent_app_type] => utility
[patent_app_number] => 12/154420
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 94
[patent_figures_cnt] => 94
[patent_no_of_words] => 72049
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20090292213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154420
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154420 | Circulatory monitoring systems and methods | May 20, 2008 | Abandoned |
Array
(
[id] => 8538507
[patent_doc_number] => 08314227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-20
[patent_title] => 'Hydroxymethyl substituted RNA oligonucleotides and RNA complexes'
[patent_app_type] => utility
[patent_app_number] => 12/515403
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 24656
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12515403
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515403 | Hydroxymethyl substituted RNA oligonucleotides and RNA complexes | May 20, 2008 | Issued |
Array
(
[id] => 6527771
[patent_doc_number] => 20100203629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Cytoplasmic BKca Channel Intron-Containing mRNAs Contribute to the Intrinsic Excitability of Hippocampal Neurons'
[patent_app_type] => utility
[patent_app_number] => 12/597460
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15903
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597460 | Cytoplasmic BKCa channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons | Apr 24, 2008 | Issued |
Array
(
[id] => 5508582
[patent_doc_number] => 20090081789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Activation of nuclear factor kappa B'
[patent_app_type] => utility
[patent_app_number] => 12/149086
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6020
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081789.pdf
[firstpage_image] =>[orig_patent_app_number] => 12149086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/149086 | Activation of nuclear factor kappa B | Apr 24, 2008 | Abandoned |
Array
(
[id] => 5480178
[patent_doc_number] => 20090203135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Glycoconjugates of RNA Interference Agents'
[patent_app_type] => utility
[patent_app_number] => 12/108253
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22938
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203135.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108253 | Glycoconjugates of RNA interference agents | Apr 22, 2008 | Issued |
Array
(
[id] => 5379745
[patent_doc_number] => 20090191584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Transcriptional repression of sodium-iodide symporter in thyroid carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/081790
[patent_app_country] => US
[patent_app_date] => 2008-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 18458
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191584.pdf
[firstpage_image] =>[orig_patent_app_number] => 12081790
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/081790 | Transcriptional repression of sodium-iodide symporter in thyroid carcinoma | Apr 20, 2008 | Issued |
Array
(
[id] => 4792168
[patent_doc_number] => 20080293142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Multiple shRNA Expression Vectors and Methods of Construction'
[patent_app_type] => utility
[patent_app_number] => 12/105428
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14985
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293142.pdf
[firstpage_image] =>[orig_patent_app_number] => 12105428
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/105428 | Multiple shRNA Expression Vectors and Methods of Construction | Apr 17, 2008 | Abandoned |
Array
(
[id] => 6453547
[patent_doc_number] => 20100154071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/450132
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 26697
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20100154071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450132 | FXDY5 MODULATORS FOR TREATING, DIAGNOSING, AND DETECTING CANCER | Mar 27, 2008 | Abandoned |
Array
(
[id] => 8317482
[patent_doc_number] => 08232257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-31
[patent_title] => 'RNA interference mediated inactivation of hepatitis B virus in a subject'
[patent_app_type] => utility
[patent_app_number] => 12/531752
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 14864
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12531752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531752 | RNA interference mediated inactivation of hepatitis B virus in a subject | Mar 26, 2008 | Issued |
Array
(
[id] => 5473667
[patent_doc_number] => 20090246833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Small interfering RNAS as non-specific drugs'
[patent_app_type] => utility
[patent_app_number] => 12/079594
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10620
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246833.pdf
[firstpage_image] =>[orig_patent_app_number] => 12079594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/079594 | Small interfering RNAS as non-specific drugs | Mar 26, 2008 | Abandoned |
Array
(
[id] => 10628917
[patent_doc_number] => 09347061
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Administering antisense oligonucleotides complementary to human apolipoprotein B'
[patent_app_type] => utility
[patent_app_number] => 12/532602
[patent_app_country] => US
[patent_app_date] => 2008-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30425
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12532602
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532602 | Administering antisense oligonucleotides complementary to human apolipoprotein B | Mar 23, 2008 | Issued |
Array
(
[id] => 24360
[patent_doc_number] => 07795412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells'
[patent_app_type] => utility
[patent_app_number] => 12/077504
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 115
[patent_figures_cnt] => 115
[patent_no_of_words] => 44969
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077504 | Nucleic acids encoding PRO6308 polypeptides and related vectors and host cells | Mar 17, 2008 | Issued |
Array
(
[id] => 4860305
[patent_doc_number] => 20080269155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'REMEDY OR PREVENTIVE FOR KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/049951
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18442
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269155.pdf
[firstpage_image] =>[orig_patent_app_number] => 12049951
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/049951 | REMEDY OR PREVENTIVE FOR KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE | Mar 16, 2008 | Abandoned |
Array
(
[id] => 5337299
[patent_doc_number] => 20090053763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'Tumor endothelial marker 7-alpha molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/075311
[patent_app_country] => US
[patent_app_date] => 2008-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 33571
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 54
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075311 | Tumor endothelial marker 7-alpha molecules and uses thereof | Mar 9, 2008 | Abandoned |
Array
(
[id] => 4779385
[patent_doc_number] => 20080287383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB GENE EXPRESSION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/039658
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 38693
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039658
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039658 | NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB GENE EXPRESSION AND USES THEREOF | Feb 27, 2008 | Abandoned |
Array
(
[id] => 6537218
[patent_doc_number] => 20100015706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/528786
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 37626
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528786
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528786 | NUCLEIC ACID COMPOUNDS FOR INHIBITING HIF1A GENE EXPRESSION AND USES THEREOF | Feb 27, 2008 | Abandoned |
Array
(
[id] => 5273903
[patent_doc_number] => 20090077679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'GENE SILENCING BY SYSTEMIC RNA INTERFERENCE'
[patent_app_type] => utility
[patent_app_number] => 12/035979
[patent_app_country] => US
[patent_app_date] => 2008-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12967
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20090077679.pdf
[firstpage_image] =>[orig_patent_app_number] => 12035979
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/035979 | GENE SILENCING BY SYSTEMIC RNA INTERFERENCE | Feb 21, 2008 | Abandoned |
Array
(
[id] => 8689959
[patent_doc_number] => 08389486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Methods for treating hematopoietic malignancies'
[patent_app_type] => utility
[patent_app_number] => 12/524524
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 17138
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524524 | Methods for treating hematopoietic malignancies | Jan 24, 2008 | Issued |